Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
This article compares index fund choices for retirement in 2024, focusing on S&P 500 vs Total Market performance and cost considerations.
24,938 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Over the past seven years, Chinese electric-vehicle and battery makers have channeled more than $100 billion into ove...
Mitsubishi closed a $7.5 billion acquisition of Aethon Energy's U.S. gas assets, creating Adamas Energy in Dallas. Th...
SpaceX isn’t your typical public stock, but the question remains: should spacex stock below the IPO price be a buying...
Could Palantir’s stock be meaningfully higher by 2027? This article offers a grounded forecast with base, bull, and b...
A loose, little-regulated lending network is stepping in to help small businesses cover tariffs quickly, but with ste...
FEG marks its five-year milestone by advancing SmartDeFi Launchpad, finalizing bonding curve testing, and expanding t...
Lucid Group delivered a stronger top line in Q4, but cash burn remains a key hurdle. Investors will parse the mix of ...
Ethereum rebounds from a mid-$1,700s slip, but the rebound sits at a critical crossroad. The question: is this a reli...
Identity theft can strike through loans opened in your name. This guide walks you through immediate actions, lender c...
The National Association of Realtors unveils a loan-focused podcast series designed to translate financing trends int...
Ethereum flirted with a major resistance around $2,160 before pulling back toward $2,080. Traders weigh whether this ...